BackgroundBy facilitating targeted cytotoxic delivery across various disease subtypes, antibody-drug conjugates (ADCs) have completely changed the landscape of…

Results from a phase 3 clinical trial evaluating anbenitamab (KN026; Ennituo) plus docetaxel for injection albumin-bound (HB1801) in…

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…

BackgroundTrastuzumab deruxtecan (T-DXd) was approved in 2022 for HER2-low metastatic breast cancer after prior chemotherapy, with a 2025…

The 144-week analysis of findings from the phase 3 ASC4FIRST trial (NCT04971226) presented at the 2026 American Society…

The actor and former professional wrestler Tyler Mane has revealed he has been diagnosed with breast cancer, and…